Peripheral neuropathies after BRAF and/or MEK inhibitor treatment: A pharmacovigilance study-Reference-Cited by-同舟云学术

Peripheral neuropathies after BRAF and/or MEK inhibitor treatment: A pharmacovigilance study

Published:2022-09-07 Issue:11 Volume:88 Page:4941-4949
ISSN:0306-5251
Container-title:British Journal of Clinical Pharmacology
language:en
Short-container-title:Brit J Clinical Pharma

Author:

Picca Alberto¹²^ORCID,Birzu Cristina¹²,Berzero Giulia³⁴,Sanchez‐Pena Paola⁵,Gaboriau Louise⁶,Vidil Faustine⁷,Lenglet Timothée⁸,Tafani Camille²⁹,Ricard Damien²⁹,Psimaras Dimitri¹²,Bihan Kévin²¹⁰^ORCID

Affiliation:

1. Sorbonne Université, Inserm, CNRS, UMR S 1127, Institut du Cerveau, ICM, AP‐HP, Hôpitaux Universitaires La Pitié Salpêtrière‐Charles Foix Paris France

2. OncoNeuroTox Group, Center for Patients with Neurological Complications of Oncologic Treatments, GH Pitié‐Salpêtrière et Hôpital Percy Paris France

3. Neurology Unit IRCCS San Raffaele Scientific Institute Milan Italy

4. Vita‐Salute San Raffaele University Milan Italy

5. Service de Pharmacologie médicale Pôle de Santé Publique, CHU de Bordeaux Bordeaux France

6. Centre Régional de Pharmacovigilance Service de Pharmacologie Médicale, CHU de Lille Lille France

7. Agence National de Sécurité du Médicament et des Produits de Santé Saint‐Denis France

8. Département de Neurophysiologie Clinique AP‐HP, GH Pitié‐Salpêtrière Paris France

9. Département de Neurologie, Hôpital d'instruction des Armées Percy Service de Santé des Armées Paris France

10. Département de Pharmacologie, AP‐HP, GH Pitié‐Salpêtrière Centre régional de Pharmacovigilance Paris France

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/bcp.15513

Reference38 articles.

1. Clinical Development of BRAF plus MEK Inhibitor Combinations

2. Survival in BRAF V600–Mutant Advanced Melanoma Treated with Vemurafenib

3. Five-Year Outcomes with Dabrafenib plus Trametinib in Metastatic Melanoma

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Case report: Parsonage-turner syndrome in a melanoma patient treated by BRAF/MEK inhibitors after immune checkpoint inhibitors;Frontiers in Oncology;2023-12-19

2. Neurological toxicities of targeted therapies in melanoma: a multicenter national observational study of the French Group of Skin Cancers (Groupe de Cancérologie Cutanée, GCC);Journal of Neurology;2023-12-06

3. Neuropsychiatric adverse drug reactions with oral tyrosine kinase inhibitors in metastatic colorectal cancer: an analysis from the FDA Adverse Event Reporting System;Frontiers in Oncology;2023-10-31

4. Neurological complications of cancer immunotherapy;Neurologie pro praxi;2023-10-30

5. Current drug treatment of myasthenia gravis;Current Opinion in Neurology;2023-08-30